BetterScholar BetterScholar

Q. Weng

Cancer Letters, Cell communication and signaling : CCS, Advancement of science, European Radiology, EBioMedicine, Journal of experimental & clinical cancer research : CR, BMC Cancer, Frontiers in Molecular Biosciences, Free Radical Biology & Medicine Show more
9
Role
Title
Level Year L/R
🐬 CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Minjiang Chen, A. Mao, Min Xu, Q. Weng, Jianting Mao, J. Ji 		7 2019
7
🐬
🐜 The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
12 auth. Bufu Tang, Jinyu Zhu, Jie Li, Kai Fan, Yang Gao, Shimiao Cheng, ... C. Kong, Liyun Zheng, Fazong Wu, Q. Weng, Chenying Lu, J. Ji 		7 2020
7
🐜
🐜 Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response
12 auth. Bufu Tang, Jinyu Zhu, Yajie Wang, Weiqian Chen, S. Fang, Weiyang Mao, ... Ziwei Xu, Yang Yang, Q. Weng, Zhongwei Zhao, Minjiang Chen, J. Ji 		6 2022
6
🐜
🐜 Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE
14 auth. C. Kong, Zhongwei Zhao, Weiyue Chen, Xiuling Lv, Gaofeng Shu, Miaoqing Ye, Jingjing Song, X. Ying, Q. Weng, Wei Weng, ... S. Fang, Minjiang Chen, J. Tu, J. Ji 		6 2021
6
🐜
🐜 miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
11 auth. Minjiang Chen, Liming Wu, J. Tu, Zhongwei Zhao, Xiaoxi Fan, Jianting Mao, ... Q. Weng, Xulu Wu, Li Huang, Min Xu, J. Ji 		6 2018
6
🐜
🐜 CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
14 auth. Zhongwei Zhao, Jingjing Song, Bufu Tang, S. Fang, Dengke Zhang, Liyun Zheng, Fazong Wu, Yang Gao, Chunmiao Chen, Xiang-hua Hu, ... Q. Weng, Yang Yang, J. Tu, J. Ji 		6 2020
6
🐜
🐜 Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells
11 auth. Xiu-hua Zhang, Minxiao Chen, P. Zou, K. Kanchana, Q. Weng, Wenbo Chen, ... Peng Zhong, J. Ji, Huiping Zhou, Langchong He, G. Liang 		6 2015
6
🐜
🐜 Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
10 auth. Liyun Zheng, S. Fang, Fazong Wu, Weiqian Chen, Minjiang Chen, Q. Weng, ... Xulu Wu, Jingjing Song, Zhongwei Zhao, J. Ji 		6 2021
6
🐜
🐜 Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis.
13 auth. Bufu Tang, Jinyu Zhu, S. Fang, Yajie Wang, R. Vinothkumar, Mengyao Li, Q. Weng, Liyun Zheng, Yang Yang, Rongfang Qiu, ... Min Xu, Zhongwei Zhao, J. Ji 		5 2021
5
🐜